Amylyx Pharmaceuticals, Inc. (AMLX)

Last Three Months

30-Jan-24 -- 29-Apr-24

Time Period:

Three Months
|
Year

($270.51K) Net Amount

Buy:	0	--
Sell:	($270.51K)	$18.73 - $18.76

Company Sentiment

Other

Other

Sentiment Breakdown by Insider

0

(3)

0

(2)

0

(1)

9

0

5

+1

0

+2

0

+3

Two Year Chart

30-Apr-22 -- 29-Apr-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
18-Apr-24 8:20 PM View:	16-Apr-24 Grant 0	Klee Justin B. Co-Chief Executive Officer Director		Amylyx Pharmaceuticals, Inc. - AMLX	11% 2.84M to 3.14M	0	($77.44K)	--	$18.73	Show Txns Hide Txns

18-Apr-24 8:23 PM View:	16-Apr-24 Grant 0	Frates James M Chief Financial Officer		Amylyx Pharmaceuticals, Inc. - AMLX	105% 123.11K to 252.5K	0	($33.56K) (1%)	--	$18.73	Show Txns Hide Txns

18-Apr-24 8:21 PM View:	16-Apr-24 Grant 0	Cohen Joshua B Co-Chief Executive Officer Director		Amylyx Pharmaceuticals, Inc. - AMLX	10% 2.9M to 3.2M	0	($77.44K)	--	$18.73	Show Txns Hide Txns

18-Apr-24 8:20 PM View:	16-Apr-24 Grant 0	Mazzariello Gina Chief Legal Officer		Amylyx Pharmaceuticals, Inc. - AMLX	230% 49.08K to 161.93K	0	($82.07K) (9%)	--	$18.73 - $18.76	Show Txns Hide Txns

18-Apr-24 8:19 PM View:	16-Apr-24 Grant 0	Bedrosian Camille L Chief Medical Officer		Amylyx Pharmaceuticals, Inc. - AMLX	166% 58.33K to 155.24K	0	0	--	--	Show Txns Hide Txns